Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
1.780
+0.020 (1.14%)
At close: Jan 7, 2026, 4:00 PM EST
1.820
+0.040 (2.25%)
Pre-market: Jan 8, 2026, 8:00 AM EST
Ovid Therapeutics Market Cap
Ovid Therapeutics has a market cap or net worth of $231.73 million as of January 8, 2026. Its market cap has increased by 223.19% in one year.
Market Cap
231.73M
Enterprise Value
219.89M
1-Year Change
223.19%
Ranking
Category
Stock Price
$1.78
Market Cap Chart
Since May 5, 2017, Ovid Therapeutics's market cap has decreased from $301.40M to $231.73M, a decrease of -23.12%. That is a compound annual growth rate of -2.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 125.30M | 7.92% |
| Dec 31, 2025 | 116.10M | 75.11% |
| Dec 31, 2024 | 66.30M | -70.87% |
| Dec 29, 2023 | 227.60M | 73.61% |
| Dec 30, 2022 | 131.10M | -40.03% |
| Dec 31, 2021 | 218.60M | 49.22% |
| Dec 31, 2020 | 146.50M | -26.16% |
| Dec 31, 2019 | 198.40M | 232.33% |
| Dec 31, 2018 | 59.70M | -75.41% |
| Dec 29, 2017 | 242.80M | -19.44% |
| May 5, 2017 | 301.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 992.16B |
| Johnson & Johnson | 499.90B |
| AbbVie | 412.54B |
| UnitedHealth Group | 309.53B |
| AstraZeneca | 297.23B |
| Novartis AG | 273.49B |
| Merck & Co. | 269.55B |
| Novo Nordisk | 254.60B |